$4.46
-0.005-0.11%
Last update: Sep 2, 1:37 PM
Relmada Therapeutics Inc
RLMDNASDAQ
Relmada Therapeutics Earnings & Forecasts
Relmada Therapeutics (RLMD) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Relmada Therapeutics Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.20 | $-0.19 | $-0.14 | $-0.04 |
| Actual | $-0.11 | $-0.22 | $-0.27 | $-0.30 |
| Surprise | +45.0% | -15.8% | -92.9% | -650.0% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | — | $0 |
| Surprise | — | — | — | — |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.14 | $-0.16 | $-0.17 | $-0.19 |
| Revenue | ||||
| Consensus | — | — | — | — |
